Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
poziotinib (1 trial)
Adenocarcinoma (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Trials (1 total)
Trial APIs (1 total)